FDA’s OPQ Emerging Tech Program Plans to Help Sponsors Avoid Manufacturing Quality Failures

Drug Industry Daily
The FDA plans to use its emerging technology program to help address key pharmaceutical quality and manufacturing challenges — and also train agency reviewers on the latest processes to keep pace with industry innovation.

To View This Article:


Subscribe To Drug Industry Daily